LinoglirideAlternative Names: MCN 3935; MCN 393546
Latest Information Update: 29 Aug 1996
At a glance
- Originator Ortho-McNeil
- Class Antihyperglycaemics; Pyrrolidines; Small molecules
- Mechanism of Action KATP channel inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 29 Aug 1996 New profile
- 29 Aug 1996 Discontinued-Clinical for Diabetes mellitus in USA (PO)